Rates of sexually transmitted infections are increasing worldwide and notifications are also increasing in Australia. As many sexually transmitted infections are asymptomatic, timely and appropriate testing is needed to avoid the long-term sequelae of infection, to halt transmission and to improve associated morbidity. Testing for sexually transmitted infections has evolved over time. Although nucleic acid amplification tests have an increasing role and may enable non-invasive testing, microscopy and culture are still useful investigations for some infections.
Introduction
Effective testing for sexually transmitted infections needs to be acceptable to the patient and tailored and targeted appropriately to sexual risk. This risk is determined by factors such as the use of condoms and the number of sexual partners.
As many common sexually transmitted infections, such as chlamydia, are largely asymptomatic, doctors need to be aware of local epidemiology and at-risk groups, in order to facilitate opportunistic screening.
To determine which tests to perform, consider the patients' individual needs and concerns, sexual activity, condom use, local epidemiology and any symptoms (Table 1) . Sexual activity such as vaginal, anal or oral sex will direct from where to collect specimens. Pretest counselling and education are important.
Serology for HIV should be considered for all patients. Testing for hepatitis B should be considered for those who have not been vaccinated. Homosexually active men should routinely have additional tests for both syphilis and hepatitis A.
With most infections there is a 'window period' (Table 2) before laboratory tests become positive. This period must be considered when interpreting results.
Chlamydia
Chlamydia trachomatis is the most commonly notified sexually transmitted infection in Australia and rates have risen four -fold between 1996 and 2005. 1 In up to 80% of women and 50% of men the infection is asymptomatic. 2 If untreated, chlamydia may have serious sequelae such as pelvic inflammatory disease, ectopic pregnancy and infertility in women, and epididymitis, chronic prostatitis and urethral strictures in men. Screening is recommended for all sexually active individuals younger than 25 years regardless of condom use.
Testing
In Australia, nucleic acid amplification tests -polymerase chain reaction (PCR) and ligase chain reaction (LCR) -are accurate and reliable. The chlamydia PCR is highly specific (99-100%) with a sensitivity of 85-90%. 3 These tests allow non-invasive and self-collected sampling. One study evaluating nucleic acid amplification tests of self-collected vulval-introital specimens, first void urine samples and clinician-collected cervical samples found the self-collected swabs and urine specimens to be acceptable alternatives to cervical sampling. 4 A positive result from a chlamydia nucleic acid amplification test is likely to be a true positive. However, these tests have only been validated for use in urine, cervical and urethral samples.
Although these tests can be used to analyse samples from other sites, such as rectum and vagina, the results should be interpreted with caution.
Chlamydia trachomatis cultures are the test of choice if the results are to be used in legal investigations as culture has a high specificity. Culture also allows for antibiotic sensitivity testing, but has the disadvantage of relatively low sensitivity and high cost. Culture is also labour intensive, technically difficult and has a long turnaround time.
Herpes
Genital herpes is the clinical manifestation of infection with either herpes simplex virus type 1 or herpes simplex virus type 2 at genital sites. Infection is common and often asymptomatic. In Australia it is estimated that up to 25-30% of people are seropositive for herpes simplex virus type 2 and 80% are seropositive for herpes simplex virus type 1. 
Gonorrhoea
Notification rates for gonococcal infections are increasing.
In Australia, men who have sex with men, those who have 
Syphilis
The rates of syphilis in Australia are about 10/100 000, nearly double that in New South Wales, and up to 140/100 000 in the Northern Territory, with a national indigenous rate of 300/100 000. 8 Despite remaining fairly stable in the heterosexual community, syphilis rates continue to rise in homosexually active men. 8 Other groups in Australia at risk of syphilis include rural and remote indigenous communities and those from overseas. Most infections are detected in the late latent phase, when the patient is asymptomatic, having passed the early infectious stages unrecognised and undiagnosed.
Testing
National antenatal screening includes syphilis testing. Treponemal tests detect antibodies that are specific for treponemes. They include the treponema pallidum particle agglutination tests, treponema pallidum haemagglutination test and fluorescent treponemal antibody absorption test.
These tests are mostly used to confirm the diagnosis. The treponeme-specific tests have a sensitivity of about 80% in primary syphilis and nearly 100% thereafter. The syphilis enzyme immunoassay may be used for screening sera. It has a sensitivity of 82-100% and specificity of 97-100%. 9 The nontreponemal tests may become negative after treatment, however they may remain positive at a low titre for life.
Similarly, most of those with reactive treponemal specific tests will remain positive for life regardless of treatment or disease activity, with 15-25% of those treated in primary syphilis reverting to negative serology after several years. 10 
Other tests
For symptomatic patients with lesions suggestive of primary or secondary syphilis, direct detection methods, such as dark ground microscopy, may be used, however these are not widely available. Performed correctly, dark ground microscopy has a sensitivity of up to 74-86% and is 97% specific. However, accuracy may vary depending on the age and condition of the lesion. Microscopy also requires trained laboratory staff, specialised equipment and rigorous conditions for the storage and transport of the sample. In primary syphilis (that is, before the production of syphilis antibodies) this method is highly sensitive and specific compared to serological testing. 
Human papillomavirus
Anogenital human papillomaviruses are sexually transmitted and extremely common, with up to 75% of sexually active individuals having evidence of current or past infection. 12 Patients presenting with genital warts may have concurrent sexually transmitted infections, and appropriate screening is 
Conclusion
Accurate and appropriate screening for sexually transmitted infections is essential to prevent significant individual morbidity and mortality and is highly important for public health. As well as the diagnosis and management of each individual, opportunistic testing for other infections, safe sex advice, education and contact tracing of partners is often required.
